Stocklytics Platform
Asset logo for symbol AKYA
Akoya Biosciences
AKYA53
$2.49arrow_drop_down2.35%-$0.05
Penny Stock
Asset logo for symbol AKYA
AKYA53

$2.49

arrow_drop_down2.35%

Performance History

Chart placeholder
Key Stats
Open$2.46
Prev. Close$2.55
EPS-1.16
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$123.41M
PE Ratio-
LOWHIGH
Day Range2.22
2.58
52 Week Range1.88
6.31
Ratios
EPS-1.16

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Akoya Biosciences (AKYA)

Akoya Biosciences, Inc. (AKYA) is a leading provider of spatial biology solutions, enabling researchers to understand the complex interactions and relationships between cells in tissues. The company's innovative technology, the CODEX platform, allows for highly multiplexed imaging of cells and proteins in the context of intact tissue samples. This powerful tool provides researchers with a comprehensive view of the spatial organization and functional characteristics of cells, enabling a deeper understanding of disease mechanisms and the development of targeted therapies.
One of the key advantages of the CODEX platform is its ability to simultaneously image a large number of biomarkers, allowing for high-throughput analysis and improved data quality. This is particularly important in the field of immuno-oncology, where the tumor microenvironment plays a critical role in cancer progression and response to therapy. By providing a detailed spatial map of immune cells and their interactions with tumor cells, the CODEX platform can help identify novel biomarkers and inform the development of immunotherapies.
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Brian McKelligon
Headquarters
Marlborough
Employees
369
Exchange
NASDAQ
add Akoya Biosciences to watchlist

Keep an eye on Akoya Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Akoya Biosciences's (AKYA) price per share?

The current price per share for Akoya Biosciences (AKYA) is $2.49. The stock has seen a price change of -$0.06 recently, indicating a -2.35% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Akoya Biosciences (AKYA)?

For Akoya Biosciences (AKYA), the 52-week high is $6.31, which is 153.41% from the current price. The 52-week low is $1.88, the current price is 32.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Akoya Biosciences (AKYA) a growth stock?

Akoya Biosciences (AKYA) has shown an average price growth of -3.95% over the past three years. It has received a score of 8 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Akoya Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Akoya Biosciences (AKYA) stock price performance year to date (YTD)?

As of the latest data, Akoya Biosciences (AKYA) has a year-to-date price change of -47.91%. Over the past month, the stock has experienced a price change of 15.28%. Over the last three months, the change has been -13.54%. Over the past six months, the figure is 11.66%.
help

Is Akoya Biosciences (AKYA) a profitable company?

Akoya Biosciences (AKYA) has a net income of -$63.32M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 58.27% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -47.47% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $96.63M, with a revenue growth rate of 29.09%, providing insight into the company's sales performance and growth. The gross profit is $56.3M. Operating income is noted at -$57.67M. Furthermore, the EBITDA is -$39.49M.
help

What is the market capitalization of Akoya Biosciences (AKYA)?

Akoya Biosciences (AKYA) has a market capitalization of $123.41M. The average daily trading volume is 2.46, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level